¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"monaural loudness balance test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • somatic evoked potential test
    ¸öÀ¯¹ßÀüÀ§°Ë»ç
  • specific gravity test
    ºñÁß½ÃÇè
  • speech discrimination test
    ¾îÀ½¸í·áµµ°Ë»ç
  • speech hearing test
    ¸»¼Ò¸®µè±â°Ë»ç, ¾îÀ½Ã»·Â°Ë»ç
  • speech reception threshold test
    ¾îÀ½Ã»Ã뿪ġ°Ë»ç
  • sperm activity grade test
    Á¤Àڿµî±Þ°Ë»ç
  • spot test
    Á¡Àû°Ë»ç
  • stamp test
    ¿ìÇ¥ÆÄ¿­°Ë»ç
  • standard double two step test
    Ç¥ÁØÀÌÁßÀ̴ܰè°Ë»ç
  • station test
    Á¤Áö°Ë»ç
  • statistical test
    Åë°è°ËÁ¤
  • sterility test
    ºÒÀÓ°Ë»ç, ¹«±Õ°Ë»ç
  • stimulation test
    Àڱذ˻ç
  • straight leg raising test
    »¸Àº¹ß¿Ã¸²°Ë»ç, ÇÏÁöÁ÷°Å»ó°Ë»ç
  • stress test
    ºÎÇϰ˻ç, Àڱذ˻ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • hemagglutination test
    Ç÷±¸ÀÀÁý¹ý
  • hemagglutination test
    Ç÷±¸ÀÀÁý °Ë»ç
  • hemagglutination test
    (Àû)Ç÷±¸ÀÀÁý½ÃÇè.
  • hemagglutination-inhibition (HI) test
    Ç÷±¸ÀÀÁý ÀúÁö½ÃÇè
  • hematoporphyrin test
    Ç츶ÅäÆ÷¸£ÇǸ°½ÃÇè.
  • hemin test
    Çì¹Î°Ë»ç(¡­ËþÞÛ).
  • hemoccult test
    ÀáÇ÷½ÃÇè
  • hemoglobin test
    Çì¸ð±Û·Îºó½ÃÇè.
  • hemoglobin test
    Çì¸ð±Û·Îºó½ÃÇè
  • hemolytic plaque test
    ¿ëÇ÷ÇöóÅ©Å×½ºÆ®.
  • hemosiderin test
    Çì¸ð½Ãµ¥¸°Å×½ºÆ®, Ç÷ö¼Ò½ÃÇè(úìôÑáÈãËúÐ).
  • hemosiderin test
    Çì¸ð½Ãµ¥¸°Å×½ºÆ®, Ç÷ö¼Ò½ÃÇè(̴̧ËÛËàÌ´).
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(¡­Ò±àõãËúÐ).
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(?ËÀËÛËàÌ´).
  • heparin tolerance test
    ÇìÆÄ¸°³»¼º½ÃÇè.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • developmental test of visual motor integration
    ½Ã°¢¿îµ¿ÅëÇÕ(ãÊÊÆê¡ÔÑ÷Öùê)¹ß´Þ°Ë»ç(Û¡Ó¹ËþÞÛ)
  • deviation test
    ÆíÀǰ˻ç
  • dexamethasone suppression test
    µ¦»ç¸ÞŸÁ¸¾ïÁ¦½ÃÇè
  • dexamethasone supression test=DST
    µ¦»ç¸ÞŸ¼Õ ¾ïÁ¦°Ë»ç(åäð²ËþÞÛ)
  • diabetes mellitus,oral glucose tolerance test
    °æ±¸´çºÎÇÏ °Ë»ç(ÌèÏ¢ÓØÝ¶ùà ËþÞÛ)
  • diagnex blue test
    µð¾Æ±×³Ø½ºÃ»»ö½ÃÇè
  • dialy test
    Åõ¼®½ÃÇè(÷âà´ãËúÐ).
  • diazepam breath test
    ´ÙÀ̾ÆÁ¦ÆÊÈ£Èí½ÃÇè
  • dilution test
    Èñ¼®½ÃÇè
  • dilution test
    ¹±Èû½ÃÇè(¡­ãËúÐ), Èñ¼®½ÃÇè.
  • dilution, routine test (RTD)
    »ó¿ëÈñ¼®¹ý
  • dinitrophenylhydrazine test
    µð´ÏÆ®·ÎÆä´ÒÈ÷µå¶óÁø½ÃÇè
  • direct agglutination test
    Á÷Á¢ÀÀÁý½ÃÇè
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°½ÃÇè.
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°°Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
HT Hashimoto thyroiditis; hearing test; hearing threshold; heart; heart transplantation, heart transpla...
IAT instillation abortion time; iodine azide test; invasive activity test
IHT insulin hypoglycemia test; intravenous histamine test; ipsilateral head turning
MET maximal exercise test; metabolic equivalent of the task; metastasis, metastatic; methionine; midexpi...
MRT magnetic resonance tomography; maximum relaxation time; median range score; median reaction time; me...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
IHLT Indirect haemolysis test
ITT Insulin Tolerance Test
ICT Intra Oral Cariogenicity Test
IAT Intracarotid amobarbital test
IDST intradermal skin test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • labyrinthine test
    ¹Ì·Î °Ë»ç
  • lactose tolerance test
    ¶ôÅä¿À½º ³»¼º ½ÃÇè
  • Lancaster test
    ¶õÄ«½ºÅÍ °Ë»ç
  • Lange's test
    ¶û°Ô ½ÃÇè
  • Laurells test
    ¶ó¿ì·¼ ·ÎÄÉÆ®Çü ¸é¿ª Àü±â ¿µµ¿¹ý
  • lepromin test
    ·¹ÇÁ·Î¹Î °Ë»ç, ·¹ÇÁ·Î¹Î ½ÃÇè
  • leukocyte bactericidal capacity test
    ¹éÇ÷±¸ »ì±Õ·Â °Ë»ç¹ý
  • leukocyte pagocytosis test
    ¹éÇ÷±¸ Ž½Ä ´É·Â °Ë»ç¹ý
  • levulose test
    °ú´ç ½ÃÇè
  • Liley test
    ¸±¸® ½ÃÇè
  • Luenbach-Koeppe test
    ·Û¹ÙÇÏ-ÄêÆä ½ÃÇè
  • Maddox double rod test
    ÀÌÁß ¸¶µ¶½ººÀ °Ë»ç, ¸¶µ¶½º ÀÌÁß°ñ ÁÙ À¯¸® °Ë»ç
  • malachite green test
    ¸È·¯Ä«ÀÌÆ® ±×¸®ÀÎ ½ÃÇè
  • Malmejde's test
    ¸»¸¶À̵¥ ½ÃÇè
    °áÇ٠ȯÀÚÀÇ ¼Òº¯ °Ë»ç.
  • Mancinis test
    ¸Ç½Ã´Ï °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
P-K test A test for the presence of immediate hypersensitivity in humans; test serum from an atopic individual is injected intradermally into a normal subject; the normal subject is challenged 24-48 hours later with the antigen suspected of causing the immediate hypersensitivity reaction in the atopic individual.
Synonym: P-K test.
(05 Mar 2000)
Morner's test For cysteine, which gives a brilliant purple colour with sodium nitroprusside; for tyrosine, which gives a green colour on boiling with sulfuric acid containing formaldehyde.
(05 Mar 2000)
Wheeler-Johnson test Cystosine or uracil when treated with bromine yields dialuric acid which gives a green colour with excess of barium hydroxide.
(05 Mar 2000)
Moschcowitz test Demonstration of lower limb ischemia by occlusion of the arterial circulation for five minutes with a tourniquet or Esmarch bandage. Following release, skin colour normally will return in a few seconds; with arterial obstruction (e.g., arteriosclerotic) colour returns more slowly.
(05 Mar 2000)
Mosenthal test An infrequently used test to evaluate renal concentrating ability by measuring the density of urine every two hours during the ingestion of a controlled diet.
(05 Mar 2000)
motility test A test based on microscopic observation or on the spread of growth in soft agar, used to determine if a microorganism is motile.
(05 Mar 2000)
motility test medium A culture medium with a concentration of agar that produces a less solid consistency than usual and allows motile organisms to grow away from the line of inoculation; used to differentiate species of bacteria.
(05 Mar 2000)
Motulsky dye reduction test A test for glucose-6-phosphate dehydrogenase deficiency in the blood, using a mixture of brilliant cresyl blue, glucose-6-phosphate, and NADP.
(05 Mar 2000)
widal test <investigation> A test involving agglutination of typhoid bacilli when they are mixed with serum containing typhoid antibodies from an individual having typhoid fever, used to detect the presence of Salmonella typhi and s. Paratyphi.
Pronounced: vidal
(13 Nov 1997)
complementation-fixation test <investigation> A test for the presence of antibodies in a serum, based on whether an antigen and complement, when put together with some red blood cells, are able to destroy them. If the red blood cells are destroyed, then antibodies were not present to prevent it. If the red blood cells are not destroyed, then antibodies were present to combine with the antigen and bind the complement, making them unable to attack the red blood cells.
(09 Oct 1997)
complement-fixation test An immunological test for determining the presence of a particular antigen or antibody when one of the two is known to be present, based on the fact that complement is "fixed" in the presence of antigen and its specific antibody.
See: Bordet-Gengou phenomenon.
(05 Mar 2000)
plasmacrit test A serologic screening method used as an aid in the diagnosis of syphilis; after only a few drops of heparinised blood (obtained from a pricked finger) are collected in a special capillary tube, the capillary tube is centrifugated in order to collect plasma, which is then mixed with a 0.01-ml drop of antigen (cardiolipin previously treated with choline chloride as an anti-inhibitor, in order to avoid falsely negative results that may occur with nonheated plasma or serum). After mechanically agitating the antigen-plasma mixture for 4 min, the presence or absence of flocculation is observed. A positive result should not be regarded as conclusively diagnostic, but a negative result excludes the likelihood of syphilis.
(05 Mar 2000)
mucin clot test A test that reflects the polymerization of synovial fluid hyaluronate; a few drops of synovial fluid added to acetic acid form a clot; poor clot formation occurs in a variety of inflammatory conditions including septic arthritis, gouty arthritis, and rheumatoid arthritis.
Synonym: Ropes test.
(05 Mar 2000)
platelet aggregation test A test of the ability of platelets to adhere to each other and hence form a haemostatic plug to prevent bleeding; failure to aggregate occurs in several conditions, e.g., thrombasthenia, Von Willebrand's disease, and following administration of aspirin, phenylbutazone, and indomethacin; the test is conducted by quantitating the decrease in turbidity that occurs in platelet-rich plasma following the in vitro addition of one or several platelet-aggregating agents (e.g., ADP, epinephrine, or serotonin).
(05 Mar 2000)
Mulder's test A qualitative test for proteins; a yellow product is formed by reacting proteins with hot, concentrated nitric acid.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á